BriaCell Therapeutics BCTX
NASDAQ BCTX
$3.41 -0.19 (-5.28%)
At close: Oct 22, 2026 · 4:00 PM EDT

BriaCell Therapeutics (BCTX) Other Operating Expenses (2021 - 2022)

Updated

BriaCell Therapeutics (BCTX) posted Other Operating Expenses of -$37,567 for fiscal Q3 2022 (quarter ended Apr 30, 2022).

Analysis

BriaCell Therapeutics (BCTX) Other Operating Expenses (2021 - 2022) Analysis & Trends

For FY2021 (ended Jul 31, 2021), BriaCell Therapeutics' Other Operating Expenses came in at -$11,137.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 BriaCell Therapeutics 25.01 Mn -55.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2022 -37,567.00
Jan 31, 2022 -28,975.00
Jul 31, 2021 -2,537.00
Apr 30, 2021 -8,228.00
Jan 31, 2021 -13,176.00
API Access

BriaCell Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BCTX&period=max&api_key=YOUR_API_KEY